Misc

Question 1

Phase 3

Clinical trials

Answer 1

• CT vs SOC

- Required Data monitoring Comittees are required to protect the safety of the trial participants

Question 2

Population at particular risk for under treatment of

Pain symptoms

At the end of life

Answer 2

Elderly
Women
Minorities

Question 3

Resource utilization

What is this for oncology nursing practice?

Answer 3

Resource utilization requires the onc-Rn to

• evaluate
• critique
• mobilize the most appropriate resources to max the patient outcomes

Data- identify, monitor , and improve the effectiveness of oncology nursing care

Question 4

Phase 2

Patient selection

Answer 4

• Phase 2
• good performance status
  -specific Sz
  -minimal exposure to chemo
  At least 1 or 2 prior regimen

Question 5

Patient requiring chronic PLT transfusions may develop antibodies and
Require further products to be ?

Answer 5

Leukoreduced -

= PLT concentrate
= Radom PLT

that has the vast majority of its WBC remove to prevent complications of blood transfusion

Question 6

Naproxen(NSAID)+acetylsalicytic acid

Cox-1

With heart issue

What to do to protect?

Answer 6

Both - cylooxygenese-a inhibitors

Who are at high risk based on existing cardiac disease

Should consider taking

Cytoprotectant

Question 7

Mitosis

Answer 7

Shortest phase in cell cycle

Question 8

Targeted and immunotherapy

Side effect

Answer 8

Skin reaction common
-yellow crusted applies and itching

Tx-dimethicone lotion

To provide additional moisture to dry irritated skin

Question 9

Tools for conversation:
ALARM
SPIKES
BETTER
PLISSIT

Answer 9

• ALARM: sexual health

- SPIKES: difficult conversation/hospice

Question 10

Important reminders

Answer 10

JCO - errors

Dyspnea - opiods